Compound Profile: Tamdosin D 0.5/0.
Tamdosin D 0.5/0.4mg is a dual-combination pharmaceutical preparation manufactured by Corona Remedies Pvt. Ltd. containing tamsulosin hydrochloride 0.4mg and dutasteride 0.5mg. This research-grade formulation represents a sophisticated approach to studying combined alpha-1 adrenergic receptor antagonism and 5-alpha reductase enzyme inhibition in laboratory settings. Researchers at Stroid UK Shop investigate this compound for its unique dual-mechanism profile in urological research models. The preparation allows scientists to examine synergistic pathways involving smooth muscle relaxation and hormonal modulation in controlled experimental conditions.
Laboratory Applications
Research scientists utilise Tamdosin D to examine complex interactions between alpha-1 receptor blockade and dihydrotestosterone synthesis inhibition in various tissue models. The tamsulosin component demonstrates selective antagonism at alpha-1A and alpha-1D receptor subtypes, particularly relevant in prostate and bladder neck research. Meanwhile, dutasteride exhibits potent inhibition of both type I and type II 5-alpha reductase enzymes, enabling comprehensive studies of androgen metabolism. Laboratory investigations focus on tissue-specific responses, pharmacokinetic interactions, and molecular pathway analysis in preclinical models. Researchers studying general health compounds often incorporate this preparation alongside other therapeutic agents. The dual-action profile makes it particularly valuable for examining complex urological pathophysiology mechanisms in controlled research environments.
Research Specifications
| Active Components | Tamsulosin HCl 0.4mg, Dutasteride 0.5mg |
|---|---|
| Manufacturer | Corona Remedies Pvt. Ltd. |
| Presentation | Dual-release capsule formulation |
| Research Classification | Alpha-1 antagonist/5AR inhibitor combination |
| Storage Requirements | Room temperature, dry environment |
| Mechanism | Dual receptor antagonism + enzyme inhibition |
The preparation requires careful handling protocols to maintain research integrity. Scientists examining therapeutic combinations often compare results with isolated compounds available in our SARMs collection and peptides range to understand selective versus combined mechanisms.
Research Compliance
Tamdosin D 0.5/0.4mg is supplied strictly for in-vitro laboratory research purposes only. This pharmaceutical preparation is not intended for human consumption, clinical application, or therapeutic use. Researchers must maintain appropriate laboratory safety protocols and regulatory compliance when conducting studies with this dual-combination compound preparation.
